Ophthalmology · Waltham, MA
NPI
1265813992
Since 2015
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1601 Trapelo Rd Ste 184
Waltham, MA, 02451
Phone (781) 890-1023
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
1,380 services
Medicare patients, 2024
401
Average age 73
Drug cost, 2024
$445K
1,319 prescriptions
Company payments, 2025
$50K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nandini Venkateswaran was code 99214 (office e&m - established), 235 times for 183 patients. In total Nandini Venkateswaran billed 1,380 services in 43 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 235 | 183 | $101.18 | $24K |
| 92025 Test - Miscellaneous | Office | 225 | 196 | $29.15 | $6,559 |
| 92136 Ultrasound - Nonspecific | Office | 149 | 147 | $36.42 | $5,427 |
| 99213 Office E&M - Established | Office | 129 | 104 | $73.00 | $9,417 |
| 99204 Office E&M - New | Office | 88 | 88 | $118.49 | $10K |
| 68841 Eye | Facility | 81 | 64 | $13.82 | $1,120 |
| 66984 Cataract Surgery | Facility | 67 | 52 | $463.47 | $31K |
| 66982 Cataract Surgery | Facility | 49 | 40 | $628.45 | $31K |
| 76514 Ultrasound - Nonspecific | Office | 48 | 35 | $9.56 | $459 |
| 92134 Computerized Ophthalmic Imaging | Office | 40 | 35 | $32.38 | $1,295 |
| 92014 Ophthalmological E&M | Office | 31 | 31 | $97.77 | $3,031 |
| 68761 Eye | Office | 27 | 13 | $93.82 | $2,533 |
| 92025 Test - Miscellaneous | Facility | 20 | 16 | $13.85 | $277 |
| 92136 Ultrasound - Nonspecific | Facility | 20 | 19 | $21.65 | $433 |
| 99203 Office E&M - New | Office | 15 | 15 | $96.70 | $1,450 |
By year: 2022 $137K for 1,072 services; 2023 $119K for 1,007 services; 2024 $166K for 1,380 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nandini Venkateswaran prescribed most often to Medicare patients was Prednisolone Acetate, with 268 prescriptions and refills. In total Nandini Venkateswaran wrote 1,319 Medicare prescriptions that cost $445K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 268 | 337 | 130 | $8,794 |
| Moxifloxacin Moxifloxacin Hcl | 104 | 104 | 41 | $2,059 |
| Ketorolac Tromethamine Generic | 97 | 97 | 56 | $1,186 |
| Valacyclovir Valacyclovir Hcl | 88 | 118 | 23 | $3,677 |
| Restasis Cyclosporine | 70 | 98 | 23 | $61K |
| Erythromycin Erythromycin Base | 69 | 69 | 30 | $721 |
| Miebo Perfluorohexyloctane/Pf | 69 | 82 | 23 | $59K |
| Tyrvaya Varenicline Tartrate | 54 | 67 | 18 | $40K |
| Bromfenac Sodium Generic | 47 | 58 | 31 | $9,609 |
| Cyclosporine Generic | 39 | 68 | 18 | $10K |
| Doxycycline Monohydrate Generic | 37 | 58 | Under 11 | $661 |
| Loteprednol Etabonate Generic | 34 | 58 | 16 | $3,881 |
| Xiidra Lifitegrast | 33 | 42 | 11 | $29K |
| Timolol Maleate Generic | 33 | 83 | 16 | $639 |
| Zirgan Ganciclovir | 25 | 26 | Under 11 | $12K |
Brand drugs: 711 claims; generic drugs: 608 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nandini Venkateswaran $50K ($50K in general payments such as food, travel and fees) from 13 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | 6 | $31K |
| Carl Zeiss Meditec, Inc. | 4 | $7,400 |
| Sight Sciences, Inc. SGHT | 7 | $4,968 |
| Ocular Therapeutix, Inc. OCUL | 6 | $2,647 |
| Glaukos Corporation GKOS | 2 | $1,124 |
| Alcon Vision LLC ALC | 10 | $783 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $725 |
| Abbvie Inc. ABBV | 3 | $233 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $148 |
| Dompe US, Inc. | 1 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.